Ligand validation:5ITE

OLB: (2S)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate

OLB is a Ligand Of Interest in 5ITE designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5ITE_OLB_C_304	3%	52%	0.313	0.641	0.93	0.91	1	1	4	0	100%	1
5ITE_OLB_A_302	1%	51%	0.355	0.574	0.93	0.98	1	1	1	0	100%	1
5ITE_OLB_B_305	0%	49%	0.462	0.51	0.93	1.04	1	2	4	0	100%	1
5ITC_OLB_C_304	29%	56%	0.179	0.837	0.9	0.82	1	-	2	0	100%	1
5KKH_OLB_B_303	14%	49%	0.219	0.773	0.94	1.01	1	1	6	0	100%	1
4KPP_OLB_A_502	41%	46%	0.17	0.892	1.07	1.02	2	1	0	0	96%	0.96
5LX9_OLB_A_409	37%	93%	0.177	0.876	0.19	0.3	-	-	1	0	100%	0.64
6XLP_OLB_A_616	34%	61%	0.182	0.908	0.8	0.69	-	-	1	0	76%	0.76
5IUB_OLB_A_2421	34%	53%	0.166	0.898	0.93	0.89	2	1	0	0	72%	0.72
7AVN_OLB_B_314	34%	39%	0.105	0.863	1.2	1.18	1	1	3	0	56%	0.56

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.